Recent findings presented at the 26th International AIDS Conference have underscored a significant advancement in HIV treatment, with an investigational…
Read More
The biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-ups
The biotech sector continues its rapid evolution, marked this week by advancements poised to streamline laboratory processes, democratize powerful AI…
Read More
The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
The past two weeks have witnessed a significant acceleration in the biopharmaceutical landscape, marked by a flurry of strategic partnerships…
Read More
Recent Biotech Bi-Weekly Highlights Breakthroughs in Alzheimer’s Modeling and Lab Automation, Fueling Drug Discovery Hopes
In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…
Read More
Biotech Bi-Weekly Delivers Insight into Breakthrough Product Launches, Strategic Alliances, and Financial Shifts Shaping the Industry
This edition of the biotech bi-weekly highlights a series of pivotal advancements, from revolutionary product introductions that promise to reshape…
Read More
Biotech Bi-Weekly: Pioneering Product Launches, Strategic Alliances, and Significant Financial Movements Shape the Industry
The dynamic landscape of biotechnology continues to evolve at an accelerated pace, marked by a flurry of innovative product launches,…
Read More
The biotech bi-weekly: a virtual biology initiative, a new discovery grant and a protein supplier to watch in cancer research in 2026
This edition of the biotech bi-weekly brings into sharp focus a vibrant landscape of innovation, marked by significant grant launches,…
Read More
Novo Nordisk Secures FDA Approval for Awiqli, a Once-Weekly Basal Insulin for Adults with Type 2 Diabetes
The United States Food and Drug Administration (FDA) has granted approval to Novo Nordisk for Awiqli (insulin icodec-abae) injection 700…
Read More
The biotech bi-weekly: genome editing, life-extending therapeutics, an early-stage biotech hub and more
The biopharmaceutical and biotechnology sectors have recently experienced an extraordinary period of accelerated activity, marked by a rapid succession of…
Read MoreYOU MAY HAVE MISSED
